These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2922053)

  • 21. Identification of the catalytic residues of AroA (Enolpyruvylshikimate 3-phosphate synthase) using partitioning analysis.
    Mizyed S; Wright JE; Byczynski B; Berti PJ
    Biochemistry; 2003 Jun; 42(23):6986-95. PubMed ID: 12795593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystal structures of the free and liganded form of an esterolytic catalytic antibody.
    Wedemayer GJ; Wang LH; Patten PA; Schultz PG; Stevens RC
    J Mol Biol; 1997 May; 268(2):390-400. PubMed ID: 9159478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of important residues in metal-chelate recognition by monoclonal antibodies.
    Delehanty JB; Jones RM; Bishop TC; Blake DA
    Biochemistry; 2003 Dec; 42(48):14173-83. PubMed ID: 14640685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Site-directed mutagenesis of active site contact residues in a hydrolytic abzyme: evidence for an essential histidine involved in transition state stabilization.
    Miyashita H; Hara T; Tanimura R; Fukuyama S; Cagnon C; Kohara A; Fujii I
    J Mol Biol; 1997 Apr; 267(5):1247-57. PubMed ID: 9150409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Off-the-shelf proteins that rival tailor-made antibodies as catalysts.
    Hollfelder F; Kirby AJ; Tawfik DS
    Nature; 1996 Sep; 383(6595):60-2. PubMed ID: 8779715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positional ordering of reacting groups contributes significantly to the efficiency of proton transfer at an antibody active site.
    Seebeck FP; Hilvert D
    J Am Chem Soc; 2005 Feb; 127(4):1307-12. PubMed ID: 15669871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of three selenium-containing catalytic antibodies with high catalytic efficiency using a novel hapten design method.
    Su D; Ren X; You D; Li D; Mu Y; Yan G; Zhang Y; Luo Y; Xue Y; Shen J; Liu Z; Luo G
    Arch Biochem Biophys; 2001 Nov; 395(2):177-84. PubMed ID: 11697854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catalytic antibodies that hydrolyze (-)-cocaine obtained by a high-throughput procedure.
    Cashman JR; Berkman CE; Underiner GE
    J Pharmacol Exp Ther; 2000 Jun; 293(3):952-61. PubMed ID: 10869397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catalysis on the coastline: theozyme, molecular dynamics, and free energy perturbation analysis of antibody 21D8 catalysis of the decarboxylation of 5-nitro-3-carboxybenzisoxazole.
    Ujaque G; Tantillo DJ; Hu Y; Houk KN; Hotta K; Hilvert D
    J Comput Chem; 2003 Jan; 24(1):98-110. PubMed ID: 12483679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of phenylphosphocholine-carrier conjugates to the combining site of antibodies maintains a conformation of the hapten.
    Barbar E; Martin TM; Brown M; Rittenberg MB; Peyton DH
    Biochemistry; 1996 Mar; 35(9):2958-67. PubMed ID: 8608133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanistic analysis of the phosphonate transition-state analogue-derived catalytic and non-catalytic antibody.
    Nishi Y; Yamamoto N; Shimazaki K; Takahashi-Ando N; Kakinuma H; Jialin S; Ruzheinikov SN; Muranova TA; Rice DW; Kajihara Y
    J Biochem; 2007 Oct; 142(4):421-33. PubMed ID: 17981825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catalytic polyclonal antibodies.
    Stephens DB; Iverson BL
    Biochem Biophys Res Commun; 1993 May; 192(3):1439-44. PubMed ID: 8507208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simple method for selecting catalytic monoclonal antibodies that exhibit turnover and specificity.
    Tawfik DS; Zemel RR; Arad-Yellin R; Green BS; Eshhar Z
    Biochemistry; 1990 Oct; 29(42):9916-21. PubMed ID: 2271630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical analysis of antibody catalysis.
    Hilvert D
    Annu Rev Biochem; 2000; 69():751-93. PubMed ID: 10966475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Site-Directed Chemical Mutations on Abzymes: Large Rate Accelerations in the Catalysis by Exchanging the Functionalized Small Nonprotein Components.
    Ishikawa F; Shirahashi M; Hayakawa H; Yamaguchi A; Hirokawa T; Tsumuraya T; Fujii I
    ACS Chem Biol; 2016 Oct; 11(10):2803-2811. PubMed ID: 27552288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic analysis of the perivascular distribution of bifunctional antibodies and haptens: comparison with experimental data.
    Baxter LT; Yuan F; Jain RK
    Cancer Res; 1992 Oct; 52(20):5838-44. PubMed ID: 1394212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical reactivity at an antibody binding site elicited by mechanistic design of a synthetic antigen.
    Tramontano A; Janda KD; Lerner RA
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6736-40. PubMed ID: 3462723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune recognition, antigen design, and catalytic antibody production.
    Tramontano A
    Appl Biochem Biotechnol; 1994; 47(2-3):257-73; discussion 273-5. PubMed ID: 7944342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. At the crossroads of chemistry and immunology: catalytic antibodies.
    Lerner RA; Benkovic SJ; Schultz PG
    Science; 1991 May; 252(5006):659-67. PubMed ID: 2024118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An investigation of antibody acyl hydrolysis catalysis using a large set of related haptens.
    Odenbaugh AL; Helms ED; Iverson BL
    Bioorg Med Chem; 2000 Feb; 8(2):413-26. PubMed ID: 10722164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.